Small Cell Lung Cancer Treatment Landscape: Hope is on the Horizon - 03/19/24 - Living Room Series

In this month's episode of the Lung Cancer Living Room™, host Danielle Hicks, Chief Patient Officer at the GO2 for Lung Cancer, leads a transformative discussion on small cell lung cancer with Dr. Jared Weiss, Professor of Medicine and Section Chief of Thoracic and Head and Neck Oncology at the University of North Carolina. Dr. Weiss, a returning guest to the Living Room, shares insights into the current treatment options for small cell lung cancer, the exciting advancements on the horizon in research, and the vital role of empowerment and education in the patient community.
The episode delves into the nature of lung cancer, the differences between non-small cell lung cancer and small cell lung cancer, and the significant recent advances in understanding and treating small cell lung cancer. Dr. Weiss explains the science behind cancer, the development of resistance, and the promise of targeted therapies and precision medicine in improving treatment outcomes.
Danielle and Dr. Weiss also discuss the importance of regular monitoring, the role of clinical trials in advancing treatment options, and the challenge of overcoming resistance to therapy. The conversation highlights GO2's dedication to small cell lung cancer research, particularly through the "Succeed" study, and their efforts in community engagement and patient support.
Bonnie Addario, co-founder of GO2 and a lung cancer survivor, joins the discussion, emphasizing the progress made in small cell lung cancer research and the ongoing need for innovative approaches to treatment.
This episode is a call to action for patients and healthcare providers to engage in open dialogue and proactive planning in the fight against small cell lung cancer, underscoring the importance of access to clinical trials and expert care facilitated by the GO2 for Lung Cancer.

[@Noodles.FreeUkraine]

I'd like to thank the extremely knowledgeable and likeable Dr. Weiss, Danielle and their respective teams for their tremendous efforts to empower patients to optimize their treatments and outcomes. Your work is highly appreciated. ♥